LUSVERTIKIMAB
UNII H1V41MWX63

Substance Identification & Data

This profile provides standardized clinical and technical data for Lusvertikimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H1V41MWX63.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2375835-91-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H1V41MWX63

CAS Registry Number

2375835-91-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LUSVERTIKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179102

National Cancer Institute reference terminology for clinical and research data.

INN ID

11533

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-194

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lusvertikimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUSVERTIKIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4 (100-LEUCINE,230-PROLINE,447-PROLINE), ANTI-(HUMAN INTERLEUKIN-7 RECEPTOR SUBUNIT .ALPHA.) (HUMAN-RATTUS NORVEGICUS MONOCLONAL OSE-127 .GAMMA.4-CHAIN), DISULFIDE WITH (31-GLUTAMINE,53-THREONINE) HUMAN-RATTUS NORVEGICUS MONOCLONAL OSE-127 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS IL7R (INTERLEUKIN 7 RECEPTOR, CD127, IL7RA)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HUMANIZED (1-449) (VH (HOMO SAPIENS IGHV3-11*01 (90.8%) -(IGHD) -IGHJ4*01 (100%)) CDR-IMGT (8.8.15) (26-33.51-58.97-111) (1-122)-HOMO SAPIENS IGHG4*01 (100%), G4V5 H P10 (CH1 (123-220), HINGE 1-12 S10>P (230) (221-232), CH2 (233-342), CH3 (343-447), CHS (448-449)) (123-449)), (136-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-NL1*01 (86.3%) -IGKJ4*01 (91.7%)) CDR-IMGT (6.3.9) (27-32.50- 52.89-97) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (228-228'':231-231'')- BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA

LUSVERTIKIMAB [INN]

LUSVERTIKIMAB [USAN]

LUSVERTIKIMAB [WHO-DD]